CGTX Cognition Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 7, 2026
$0,93
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,55minimo 52 sett.
$2,05massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$88M
P/E
-2.9
EPS
$-0.32
i tuoi badge
Intervallo 52 sett.
$1–$2
Rating Analisti
BUY
Prezzo Obiettivo
$3
P/E
-2.9
ROE
-113.7%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CGTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.93
Capitalizzazione di Mercato (MRQ)
$88M
P/E
-2.9
EPS
$-0.32
ROE
-113.7%
Intervallo 52 sett.
$1–$2
CGTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-0.322020-12-31 → 2025-12-31
Flusso di cassa libero·2021-12-31 → 2024-12-31
Margine netto·2021-12-31 → 2023-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CGTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -2.9media 5 anni ≈-2.3 | ≈-2.3 | · | · | |
| P/S | -2937.3media 5 anni ≈-2064.1 | ≈-2064.1 | · | · | |
| P/B (MRQ) | 2.7media 5 anni ≈2.5 | ≈2.5 | 3.6 | Valore equo | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -3.3media 5 anni ≈-10.4 | ≈-10.4 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 2.4media 5 anni ≈2.5 | ≈2.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CGTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -59.8%media 5 anni ≈-59.7% | ≈-59.7% | -53.9% | In linea | |
| ROE | -113.7%media 5 anni ≈-80.5% | ≈-80.5% | -94.1% | Sotto la media |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CGTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 7.0media 5 anni ≈4.6 | ≈4.6 | 3.2 | Liquidità elevata | |
| Quick Ratio | 2.6media 5 anni ≈4.0 | ≈4.0 | 2.8 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
15.3%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 11, 2026 | $-0.04 | $-0.06 | 38.1% |
| 31 Marzo 2026 | Mag 13, 2026 | $-0.05 | $-0.07 | 27.4% |
| 31 Dicembre 2025 | $-0.05 | $-0.09 | 43.5% | |
| 30 Settembre 2025 | $-0.06 | $-0.10 | 41.2% | |
| 30 Giugno 2025 | $-0.11 | $-0.11 | -1.1% | |
| 31 Marzo 2025 | $-0.14 | $-0.11 | -24.4% | |
| 31 Dicembre 2024 | $-0.17 | $-0.14 | -17.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $37M | $42M | $37M | $30M | $19M | $13M | |
| SG&A Expense | $11M | $12M | $14M | $13M | $10M | $5M | |
| Operating Expenses | $48M | $54M | $51M | $44M | $29M | $17M | |
| Operating Income | $-48M | $-54M | $-51M | $-44M | $-29M | $-17M | |
| Other Non-op | $24M | $20M | $25M | $22M | $17M | $10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-23M | $-34M | $-26M | $-21M | $-12M | $-8M | |
| EPS (Basic) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| EPS (Diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| Shares (Basic) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| Shares (Diluted) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| EBITDA | $-48M | $-54M | $-51M | $-43M | $-29M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $25M | $30M | $42M | $55M | $5M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $2M | $544.0K | |
| Other Current Assets | · | · | · | · | $11.0K | $23.0K | |
| Current Assets | $48M | $30M | $34M | $48M | $59M | $7M | |
| PP&E (Net) | $93.0K | $181.0K | $284.0K | $233.0K | $145.0K | $211.0K | |
| PP&E (Gross) | $280.0K | $1M | $1M | $1M | $1M | $988.0K | |
| Accum. Depreciation | $187.0K | $1M | $1M | $953.0K | $870.0K | $777.0K | |
| Total Assets | $48M | $30M | $35M | $50M | $59M | $7M | |
| Accounts Payable | $1M | $2M | $4M | $3M | $4M | $2M | |
| Accrued Liabilities | $12M | $8M | $4M | $2M | $2M | $994.0K | |
| Current Liabilities | $14M | $11M | $10M | $8M | $8M | $3M | |
| Capital Leases | $195.0K | $342.0K | $520.0K | $695.0K | · | · | |
| Deferred Tax | $67.0K | $110.0K | $147.0K | $178.0K | $13.0K | $22.0K | |
| Other Non-current Liabilities | · | · | $0 | $2M | $0 | · | |
| Total Liabilities | $14M | $11M | $11M | $10M | $8M | $20M | |
| Common Stock | $90.0K | $60.0K | $32.0K | $29.0K | $22.0K | $1.0K | |
| Paid-in Capital | $233M | $194M | $166M | $156M | $145M | $222.0K | |
| Retained Earnings | $-199M | $-175M | $-141M | $-115M | $-94M | $-68M | |
| AOCI | · | · | $-195.0K | $-199.0K | $-198.0K | $-187.0K | |
| Stockholders' Equity | $34M | $19M | $24M | $40M | $51M | $-68M | |
| Liabilities + Equity | $48M | $30M | $35M | $50M | $59M | $7M | |
| Shares Outstanding | 88,904,161 | 59,854,877 | 32,165,478 | 28,991,548 | 22,230,032 | 538,793 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $36.0K | $107.0K | $96.0K | $83.0K | $93.0K | $98.0K | |
| Stock-based Comp | $2M | $4M | $4M | $4M | $5M | $475.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | $-3M | $2M | $5M | $-791.0K | $3M | · | |
| Operating Cash Flow | $-25M | $-28M | $-16M | $-19M | $-4M | $-3M | |
| CapEx | · | $4.0K | $147.0K | $171.0K | $27.0K | $10.0K | |
| Investing Cash Flow | $9.0K | $-4.0K | $-147.0K | $-171.0K | $-27.0K | $-10.0K | |
| Financing Cash Flow | $37M | $24M | $5M | $6M | $53M | $6M | |
| Net Change in Cash | $12M | $-5M | $-12M | $-13M | $50M | $2M | |
| Free Cash Flow | · | $-28M | $-16M | $-19M | $-4M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 187866.7% | 155539.3% | 3202.5% | · | |
| Net Margin | · | · | 95511.1% | 76417.9% | 1312.0% | · | |
| EBITDA Margin | · | · | 187511.1% | 155242.9% | 3192.1% | · | |
| ROA | -59.8% | -103.9% | -60.3% | -39.1% | -35.4% | · | |
| ROE | -113.7% | -204.5% | -96.6% | -53.8% | 66.1% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 | · | |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | -0.0 | -0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.31 | $0.76 | $1.39 | $2.31 | · | |
| Revenue / Share | · | · | $-0.00 | $-0.00 | $-0.17 | · | |
| Cash Flow / Share | $-0.34 | $-0.72 | $-0.53 | $-0.78 | $-0.70 | · | |
| Cash / Share | $0.41 | $0.42 | $0.93 | $1.43 | $2.46 | · | |
| EPS (TTM) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | $-27.0K | $-28.0K | $-893.0K | · | |
| Net Income TTM | $-23M | $-34M | $-26M | $-21M | $-12M | · | |
| Market Cap | $120M | $42M | $60M | $61M | $140M | · | |
| P/E | -4.2 | -0.8 | -2.2 | -2.3 | -2.0 | · | |
| P/S | -4286.5 | -1498.5 | -2203.9 | -2174.4 | -157.3 | · | |
| P/B | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Tangible Book | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Cash Flow | -4.9 | -1.5 | -3.7 | -3.3 | -38.7 | · | |
| P / FCF | · | -1.5 | -3.7 | -3.3 | -38.4 | · | |
| Earnings Yield | -23.7% | -122.7% | -46.5% | -43.3% | -49.5% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $6M | $11M | $4M | $11M | $11M | $8M | $11M | $12M | $11M | $12M | $12M | $8M | $5M | $6M | $8M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $8M | $9M | $14M | $6M | $14M | $14M | $11M | $14M | $15M | $14M | $15M | $15M | $12M | $9M | $9M | $13M | |
| Operating Income | $-8M | $-9M | $-14M | $-6M | $-14M | $-14M | $-11M | $-14M | $-15M | $-14M | $-15M | $-15M | $-12M | $-9M | $-9M | $-13M | |
| Other Non-op | $4M | $4M | $10M | $1M | $7M | $5M | $3M | $5M | $8M | $5M | $7M | $8M | $7M | $3M | $4M | $6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-6M | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-5M | $-7M | $-8M | $-8M | $-10M | $-7M | $-9M | $-8M | $-7M | $-5M | $-6M | $-5M | $-7M | |
| EPS (Basic) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| Shares (Basic) | 90,624,381 | 89,191,313 | · | 77,951,513 | 63,690,945 | 61,828,149 | · | 40,418,065 | 40,062,954 | 33,735,269 | · | 30,365,506 | 29,614,822 | 29,094,592 | · | 23,024,026 | |
| Shares (Diluted) | 90,624,381 | 89,191,313 | · | 77,951,513 | 63,690,945 | 61,828,149 | · | 40,418,065 | 40,062,954 | 33,735,269 | · | 30,365,506 | 29,614,822 | 29,094,592 | · | 23,024,026 | |
| EBITDA | $-8M | $-9M | · | $-6M | $-14M | $-14M | · | $-14M | $-15M | $-14M | · | $-15M | $-12M | $-9M | · | $-13M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $31M | $37M | $39M | $11M | $16M | $25M | $22M | $29M | $35M | $30M | $33M | $37M | $39M | $42M | $47M | |
| Prepaid Expense | $586.0K | $932.0K | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $2M | |
| Current Assets | $38M | $36M | $48M | $43M | $19M | $23M | $30M | $27M | $34M | $38M | $34M | $36M | $42M | $43M | $48M | $51M | |
| PP&E (Net) | $87.0K | $77.0K | $93.0K | $159.0K | $174.0K | $190.0K | $181.0K | $207.0K | $234.0K | $257.0K | $284.0K | $281.0K | $248.0K | $253.0K | $233.0K | $246.0K | |
| PP&E (Gross) | · | · | $280.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $187.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $953.0K | · | |
| Total Assets | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Accounts Payable | $673.0K | $4M | $1M | $827.0K | $771.0K | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $8M | |
| Accrued Liabilities | $4M | $2M | $12M | $4M | $9M | $8M | $8M | $10M | $6M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $5M | $6M | $14M | $7M | $12M | $11M | $11M | $13M | $11M | $10M | $10M | $8M | $8M | $7M | $8M | $12M | |
| Capital Leases | $422.0K | $176.0K | $195.0K | $212.0K | $229.0K | $280.0K | $342.0K | $392.0K | $440.0K | $488.0K | $520.0K | $565.0K | $608.0K | $651.0K | $695.0K | $603.0K | |
| Deferred Tax | · | · | $67.0K | · | · | · | $110.0K | · | · | · | $147.0K | · | · | · | $178.0K | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $1M | $1M | $2M | $2M | $2M | |
| Total Liabilities | $6M | $6M | $14M | $7M | $13M | $11M | $11M | $13M | $11M | $10M | $11M | $10M | $10M | $10M | $10M | $14M | |
| Common Stock | $95.0K | $90.0K | $90.0K | $88.0K | $65.0K | $62.0K | $60.0K | $41.0K | $40.0K | $40.0K | $32.0K | $30.0K | $30.0K | $29.0K | $29.0K | $24.0K | |
| Paid-in Capital | $240M | $233M | $233M | $232M | $197M | $196M | $194M | $182M | $180M | $179M | $166M | $162M | $161M | $158M | $156M | $150M | |
| Retained Earnings | $-207M | $-203M | $-199M | $-195M | $-190M | $-184M | $-175M | $-167M | $-157M | $-150M | $-141M | $-133M | $-126M | $-122M | $-115M | $-110M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-195.0K | $-196.0K | $-196.0K | $-195.0K | $-199.0K | $-201.0K | |
| Stockholders' Equity | $33M | $30M | $34M | $37M | $7M | $12M | $19M | $14M | $23M | $29M | $24M | $29M | $34M | $36M | $40M | $39M | |
| Liabilities + Equity | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Shares Outstanding | 95,055,773 | 89,353,773 | 88,904,161 | 88,268,078 | 64,962,957 | 61,974,755 | 59,854,877 | 40,806,092 | 40,112,268 | 39,985,866 | 32,165,478 | 30,417,082 | 30,286,582 | 29,277,227 | 28,991,548 | 23,969,497 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $14.0K | $15.0K | · | · | $27.0K | $27.0K | $26.0K | $27.0K | $27.0K | $25.0K | $23.0K | $21.0K | $23.0K | $22.0K | |
| Stock-based Comp | $319.0K | $330.0K | $358.0K | $522.0K | $621.0K | $586.0K | $534.0K | $896.0K | $1M | $1M | $1M | $1M | $1M | $1M | $902.0K | $777.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $709.0K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-3M | $-6M | $-6M | $-10M | $-8M | $-7M | $-6M | $-7M | $-5M | $-4M | $-4M | $-3M | $-10M | $-4.0K | |
| CapEx | · | · | · | · | · | · | $1.0K | $0 | · | · | $30.0K | $58.0K | $18.0K | $41.0K | $10.0K | $23.0K | |
| Investing Cash Flow | · | · | · | · | · | · | $-1.0K | $0 | · | · | $-30.0K | $-58.0K | $-18.0K | $-41.0K | $-10.0K | $-23.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $197.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $197.0K | · | · | |
| Financing Cash Flow | $7M | $-233.0K | $605.0K | $34M | $752.0K | $1M | $11M | $329.0K | $-138.0K | $12M | $2M | $-3.0K | $2M | $-10.0K | $5M | $869.0K | |
| Net Change in Cash | $4M | $-6M | $-3M | $28M | $-5M | $-9M | $3M | $-7M | $-6M | $5M | $-3M | $-4M | $-2M | $-3M | $-5M | $839.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | 141020.0% | · | 737250.0% | 196950.0% | 89730.0% | · | 631250.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | 91510.0% | · | 337450.0% | 78766.7% | 61720.0% | · | 331250.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | 78766.7% | 61720.0% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | 140750.0% | · | 737250.0% | 196950.0% | 89520.0% | · | 631250.0% | |
| ROA | -13.4% | -15.3% | · | -13.9% | -24.9% | -27.2% | · | -29.9% | -18.0% | -21.7% | · | -14.6% | -9.8% | -11.8% | · | -19.8% | |
| ROE | -19.6% | -21.7% | · | -19.3% | -44.8% | -41.2% | · | -45.8% | -24.5% | -28.3% | · | -19.8% | -12.1% | -14.6% | · | 28.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 5.9 | · | 6.4 | 1.5 | 2.1 | · | 2.1 | 3.1 | 4.0 | · | 4.4 | 5.3 | 5.7 | · | 4.2 | |
| Quick Ratio | 6.2 | 5.1 | · | 5.9 | 0.9 | 1.5 | · | 1.7 | 2.6 | 3.6 | · | 4.0 | 4.7 | 5.2 | · | 3.8 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.33 | · | $0.41 | $0.11 | $0.20 | · | $0.35 | $0.57 | $0.72 | · | $0.95 | $1.14 | $1.22 | · | $1.64 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $-0.00 | · | $-0.00 | $-0.00 | $-0.00 | · | $-0.00 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.16 | · | · | · | $-0.21 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.36 | $0.35 | · | $0.45 | $0.17 | $0.27 | · | $0.54 | $0.71 | $0.87 | · | $1.08 | $1.23 | $1.33 | · | $1.94 | |
| EPS (TTM) | $-0.16 | $-0.23 | · | $-0.47 | $-0.66 | $-0.73 | · | $-0.97 | $-0.94 | $-0.92 | · | $-0.79 | $-0.86 | $-0.95 | · | $10.69 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $-28.0K | $-28.0K | $-29.0K | · | $-17.0K | |
| Net Income TTM | $-17M | $-20M | · | $-28M | $-33M | $-33M | · | $-34M | $-31M | $-29M | · | $-23M | $-23M | $-24M | · | $-24M | |
| Market Cap | $109M | $68M | · | $119M | $20M | $26M | · | $19M | $67M | $73M | · | $44M | $55M | $58M | · | $46M | |
| P/E | -7.2 | -3.3 | · | -2.9 | -0.5 | -0.6 | · | -0.5 | -1.8 | -2.0 | · | -1.8 | -2.1 | -2.1 | · | 0.2 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | -1564.3 | -1979.4 | -1998.9 | · | -2678.9 | |
| P/B | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Tangible Book | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -12.3 | · | · | · | -2.6 | · | · | · | -10.0 | · | · | · | -21.4 | · | · | |
| Earnings Yield | -13.9% | -30.3% | · | -34.8% | -212.9% | -173.4% | · | -206.8% | -56.6% | -50.5% | · | -54.9% | -47.0% | -48.0% | · | 562.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margine Operativo % | · | · | 187866.7% | 155539.3% | 3202.5% |
| Utile netto | $-23M | $-34M | $-26M | $-21M | $-12M |
| EPS Diluito | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | $-28M | $-16M | $-19M | $-4M |
Proprietari istituzionali (13F) 69 filer · $30.4M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
69
Valore detenuto
$30.4M
Nuove posizioni
3
Posizioni chiuse
13
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 3 (-11 vs trimestre precedente) | 13 (+1 vs trimestre precedente) | 23 (+6 vs trimestre precedente) | 10 (-3 vs trimestre precedente) | +1.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BIOS Capital Management, LP | $6.900.001 | 6.000.000 | 22,71% | Azioni |
| DAVENPORT & Co LLC | $4.898.438 | 4.259.511 | 16,12% | Azioni |
| VANGUARD GROUP INC | $4.478.658 | 3.317.525 | 14,74% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.591 | 3.438.775 | 13,02% | Azioni |
| BlackRock, Inc. | $1.451.292 | 1.261.993 | 4,78% | Azioni |
| Chescapmanager LLC | $1.146.583 | 997.029 | 3,77% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.047.051 | 910.006 | 3,45% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $797.281 | 693.288 | 2,62% | Azioni |
| Hilton Capital Management, LLC | $631.293 | 548.950 | 2,08% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $584.453 | 508.220 | 1,92% | Azioni |
| CM Management, LLC | $517.500 | 450.000 | 1,70% | Azioni |
| Dauntless Investment Group, LLC | $427.456 | 371.701 | 1,41% | Azioni |
| Sigma Planning Corp | $416.605 | 362.265 | 1,37% | Azioni |
| STATE STREET CORP | $401.330 | 348.983 | 1,32% | Azioni |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $368.575 | 320.500 | 1,21% | Azioni |
| UBS Group AG | $251.316 | 218.536 | 0,83% | Azioni |
| AMERICAN FINANCIAL GROUP INC | $235.750 | 205.000 | 0,78% | Azioni |
| NORTHERN TRUST CORP | $204.932 | 178.202 | 0,67% | Azioni |
| Voss Capital, LP | $201.250 | 175.000 | 0,66% | Azioni |
| Texas Capital Bank Wealth Management Services Inc | $164.790 | 143.296 | 0,54% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97.681 | 84.940 | 0,32% | Azioni |
| XTX Topco Ltd | $90.242 | 78.471 | 0,30% | Azioni |
| Corient Private Wealth LP | $89.960 | 78.226 | 0,30% | Azioni |
| McAdam, LLC | $74.236 | 64.553 | 0,24% | Azioni |
| FCA CORP /TX | $60.416 | 52.536 | 0,20% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $58.478 | 50.850 | 0,19% | Azioni |
| Circle Wealth Management, LLC | $56.168 | 48.842 | 0,18% | Azioni |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $55.200 | 48.000 | 0,18% | Azioni |
| Bangor Savings Bank | $46.597 | 40.519 | 0,15% | Azioni |
| Essex Financial Services, Inc. | $46.000 | 40.000 | 0,15% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $45.521 | 40.644 | 0,15% | Azioni |
| GABELLI FUNDS LLC | $34.500 | 30.000 | 0,11% | Azioni |
| Bryn Mawr Trust Advisors, LLC | $33.408 | 29.050 | 0,11% | Azioni |
| MORGAN STANLEY | $32.054 | 27.873 | 0,11% | Azioni |
| HighTower Advisors, LLC | $30.475 | 26.500 | 0,10% | Azioni |
| PRIVATE MANAGEMENT GROUP INC | $27.600 | 24.000 | 0,09% | Azioni |
| Vanguard Global Advisers, LLC | $27.187 | 23.641 | 0,09% | Azioni |
| CWA Asset Management Group, LLC | $26.450 | 23.000 | 0,09% | Azioni |
| Creative Planning | $25.530 | 22.200 | 0,08% | Azioni |
| Qube Research & Technologies Ltd | $25.070 | 21.800 | 0,08% | Azioni |
| GAMCO INVESTORS, INC. ET AL | $23.000 | 20.000 | 0,08% | Azioni |
| Cetera Investment Advisers | $22.828 | 19.850 | 0,08% | Azioni |
| Rockefeller Capital Management L.P. | $22.116 | 19.231 | 0,07% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $20.087 | 17.467 | 0,07% | Azioni |
| Focus Partners Wealth | $19.838 | 17.250 | 0,07% | Azioni |
| Northeast Financial Consultants Inc | $19.627 | 63.351 | 0,06% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $18.344 | 15.951 | 0,06% | Azioni |
| CITIZENS FINANCIAL GROUP INC/RI | $15.731 | 13.679 | 0,05% | Azioni |
| Bank of New York Mellon Corp | $15.481 | 13.462 | 0,05% | Azioni |
| BRADLEY FOSTER & SARGENT INC/CT | $13.480 | 11.722 | 0,04% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| BIOS MEMORY SPV I, LP, BIOS MEMORY SPV II, LP, BIOS FUND I, LP, BIOS FUND I QP, LP, BP DIRECTORS, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×5 depositi | 23 Settembre 2025 | 6,80% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 13 insider · 4 dirigenti · 7 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lisa Ricciardi | CEO & President | 16 Aprile 2026 P | 1.715.851 | 1 | 0 | $10.092 |
| John Brendan Doyle | Chief Financial Officer | 01 Maggio 2026 F | 618.942 | 1 | 0 | $11.300 |
| James Michael O'Brien | Chief Financial Officer | 23 Marzo 2022 A | 5.000 | 0 | 0 | $0 |
| Anthony Caggiano | Chief Medical Officer | 16 Aprile 2026 P | 874.906 | 1 | 0 | $11.100 |
| Peggy Wallace | Direttore | 17 Giugno 2026 A | 111.461 | 0 | 0 | $0 |
| Jack A. Khattar | Direttore | 17 Giugno 2026 A | 73.500 | 0 | 0 | $0 |
| Brett P Monia | Direttore | 17 Giugno 2026 A | 73.500 | 0 | 0 | $0 |
| Ellen B Richstone | Direttore | 17 Giugno 2026 A | 83.500 | 0 | 0 | $0 |
| Fletcher Aaron G.L. | Direttore | 19 Settembre 2025 M | 56.229 | 0 | 0 | $0 |
| Mark H. Breedlove | Direttore | 13 Ottobre 2021 X | 404.439 | 0 | 0 | $0 |
| Golden Seeds Cognition Therapeutics LLC | Proprietario del 10% | 27 Settembre 2022 J | 0 | 0 | 0 | $0 |
| Ogden CAP Associates, LLC | Proprietario del 10% | 13 Ottobre 2021 X | 2.210.377 | 0 | 0 | $0 |
| BIOS MEMORY SPV I, LP | Proprietario del 10% | 13 Ottobre 2021 C | 60.065 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 4 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,08% | 6.057 SH | 11 Settembre 2026 | Giornaliero |
| IWC · iShares Trust | 0,02% | 273.424 SH | 10 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 923.898 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.444.295 SH | 19 Agosto 2026 | Giornaliero |
CGTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 9 analisti
COMPRA
Target mediano
$3.00
+224,3%
2 22,2%
Acquisto forte
6 66,7%
Compra
1 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-10-03Target medio $3.33 +260,3%
← Sotto tutti i target
Prezzo attuale $0.93
Basso$3.00
Media$3.33
Alto$4.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CGTX | $120M | -4.2 | · | · | -113.7% | · |
| PLYX | · | · | · | · | -193.7% | · |
| NMRA | $312M | -1.2 | · | · | -165.2% | · |
| NTRB | · | · | · | · | · | · |
| NTHI | · | -2.6 | -51.8% | · | · | · |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | · |
| TELO | $46M | -4.0 | · | · | -325.7% | · |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| ELOX | · | · | · | · | 30.1% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 7, 2026